BASILEA PHARMACEUTICA

DEAD

Serial Number

87980984

Owner

Basilea Pharmaceutica International Ltd.

Attorney

Evan A. Raynes

First Use Date

Apr 9, 2019

Filing Date

Nov 1, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BASILEA PHARMACEUTICA Trademark

Serial Number: 87980984 • Registration: 5795819

BASILEA PHARMACEUTICA is a trademark filed by Basilea Pharmaceutica International Ltd. on November 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Basilea Pharmaceutica International Ltd.

Grenzacherstrasse 487
Basel 4058 , CH

Entity Type: 03

BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (26 trademarks)

HEGENHEIMERMATTWEG 167B
ALLSCHWIL 4123 , CH

Entity Type: 03

Legal Representation

Attorney of Record

Evan A. Raynes

1,358 trademarks filed View all →

Correspondence Address

EVAN A. RAYNES SYMBUS LAW GROUP, LLC

1775 I STREET, NW, SUITE 1150

WASHINGTON, DC 20006

UNITED STATES

Trademark Details

Filing Date

November 1, 2016

Registration Date

July 2, 2019

First Use Anywhere

April 9, 2019

First Use in Commerce

April 9, 2019

Published for Opposition

October 3, 2017

Cancellation Date

January 16, 2026

Goods & Services

Pharmaceutical products and preparations for the treatment and prevention of infections caused by bacteria

Filing History

CANCELLED SEC. 8 (6-YR)

Jan 16, 2026 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 2, 2024 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 28, 2023 ASGN

REGISTERED-PRINCIPAL REGISTER

Jul 2, 2019 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 29, 2019 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 28, 2019 CNPR

STATEMENT OF USE PROCESSING COMPLETE

May 21, 2019 SUPC

DIVISIONAL PROCESSING COMPLETE

May 21, 2019 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 20, 2019 AITU

USE AMENDMENT FILED

May 3, 2019 IUAF

DIVISIONAL REQUEST RECEIVED

May 3, 2019 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

May 3, 2019 ERTD

TEAS STATEMENT OF USE RECEIVED

May 3, 2019 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 2, 2018 EXRA

SOU EXTENSION 2 GRANTED

Oct 31, 2018 EX2G

SOU EXTENSION 2 FILED

Oct 31, 2018 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 31, 2018 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 11, 2018 EXRA

SOU EXTENSION 1 GRANTED

May 9, 2018 EX1G

SOU EXTENSION 1 FILED

May 9, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

May 9, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 28, 2017 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 3, 2017 NPUB

PUBLISHED FOR OPPOSITION

Oct 3, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 13, 2017 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 25, 2017 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 11, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 10, 2017 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 10, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 10, 2017 GNRN

NON-FINAL ACTION E-MAILED

Feb 10, 2017 GNRT

NON-FINAL ACTION WRITTEN

Feb 10, 2017 CNRT

ASSIGNED TO EXAMINER

Feb 8, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 4, 2016 NWOS

NEW APPLICATION ENTERED

Nov 4, 2016 NWAP

Related Trademarks

More from this Owner

DATIROS

BASILEA PHARMACEUTICA

Serial #97531285

More in Same Class

RELIEF WHEN YOU NEED IT

TREXIJECT